Dysmorphic features
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
Hearing impairment and renal failure associated with RMND1 mutations.
|
26395190 |
2016 |
Dysmorphic features
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
An RMND1 Mutation causes encephalopathy associated with multiple oxidative phosphorylation complex deficiencies and a mitochondrial translation defect.
|
23022098 |
2012 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Malignant neoplasm of breast
|
0.310 |
Biomarker
|
disease |
CTD_human |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
|
29915430 |
2018 |
Breast Carcinoma
|
0.310 |
Biomarker
|
disease |
CTD_human |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
|
29915430 |
2018 |
Mammary Neoplasms, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
|
29915430 |
2018 |
Mammary Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
|
29915430 |
2018 |
Mammary Carcinoma, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
|
29915430 |
2018 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Red cell distribution width determination
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
RDW - Red blood cell distribution width result
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Acidosis, Lactic
|
0.120 |
Biomarker
|
phenotype |
HPO |
|
|
|
Seizures
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
hearing impairment
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Renal tubular acidosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Fatty Liver
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Lethargy
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Myopathy
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Hyporeflexia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Feeding difficulties
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Decreased liver function
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Absent reflex
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Renal Cell Dysplasia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital hypoplasia of kidney
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Pachygyria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|